Melissa Durand, MD
Research & Publications
Biography
News
Research Summary
Dr. Durand is a breast imaging subspecialist with a primary research role focused on breast cancer screening and diagnosis with Digital Breast Tomosynthesis (DBT). She is the recipient of several industry grants and serves as the Yale principal investigator of a multisite collaborative DBT research group that has co-authored several landmark papers on DBT. She was also the recipient of a Lion Heart Pilot grant to evaluate the clinical performance of synthesized mammography, a form of DBT that reduces radiation rates by almost 50%. Dr. Durand has presented her work at international, national and regional conferences and collaborated on several scientific manuscripts, review articles, and book chapters. Presently she is expanding her involvement in global outreach with Rad-Aid as the breast imaging lead for Ghana.
Coauthors
Research Interests
Anatomy
Selected Publications
- False-Negative Rates of Breast Cancer Screening with and without Digital Breast TomosynthesisDurand MA, Friedewald SM, Plecha DM, Copit DS, Barke LD, Rose SL, Hayes MK, Greer LN, Dabbous FM, Conant EF. False-Negative Rates of Breast Cancer Screening with and without Digital Breast Tomosynthesis. Radiology 2020, 298: 202858. PMID: 33258744, DOI: 10.1148/radiol.2020202858.
- Effect of age on breast cancer screening using tomosynthesis in combination with digital mammographyRafferty EA, Rose SL, Miller DP, Durand MA, Conant EF, Copit DS, Friedewald SM, Plecha DM, Ott IL, Hayes MK, Carlson KL, Cink TM, Barke LD, Greer LN, Niklason LT. Effect of age on breast cancer screening using tomosynthesis in combination with digital mammography. Breast Cancer Research And Treatment 2017, 164: 659-666. PMID: 28523569, DOI: 10.1007/s10549-017-4299-0.
- Synthesized Mammography: Clinical Evidence, Appearance, and ImplementationDurand MA. Synthesized Mammography: Clinical Evidence, Appearance, and Implementation. Diagnostics 2018, 8: 22. PMID: 29617294, PMCID: PMC6023509, DOI: 10.3390/diagnostics8020022.
- Early Clinical Experience with Digital Breast Tomosynthesis for Screening MammographyDurand MA, Haas BM, Yao X, Geisel JL, Raghu M, Hooley RJ, Horvath LJ, Philpotts LE. Early Clinical Experience with Digital Breast Tomosynthesis for Screening Mammography. Radiology 2014, 274: 85-92. PMID: 25188431, DOI: 10.1148/radiol.14131319.
- Tomosynthesis-detected Architectural Distortion: Management Algorithm with Radiologic-Pathologic Correlation.Durand MA, Wang S, Hooley RJ, Raghu M, Philpotts LE. Tomosynthesis-detected Architectural Distortion: Management Algorithm with Radiologic-Pathologic Correlation. Radio Graphics 2016, 36: 311-21. PMID: 26963448, DOI: 10.1148/rg.2016150093.
- Breast Cancer Screening Using Tomosynthesis in Combination With Digital MammographyFriedewald SM, Rafferty EA, Rose SL, Durand MA, Plecha DM, Greenberg JS, Hayes MK, Copit DS, Carlson KL, Cink TM, Barke LD, Greer LN, Miller DP, Conant EF. Breast Cancer Screening Using Tomosynthesis in Combination With Digital Mammography. JAMA 2014, 311: 2499-2507. PMID: 25058084, DOI: 10.1001/jama.2014.6095.
- Comparison of Tomosynthesis Plus Digital Mammography and Digital Mammography Alone for Breast Cancer ScreeningHaas BM, Kalra V, Geisel J, Raghu M, Durand M, Philpotts LE. Comparison of Tomosynthesis Plus Digital Mammography and Digital Mammography Alone for Breast Cancer Screening. Radiology 2013, 269: 694-700. PMID: 23901124, DOI: 10.1148/radiol.13130307.
- Editorial Comment: With or Without Ultrasound Correlates, Multiple Architectural Distortions Still Warrant Biopsy.Durand MA. Editorial Comment: With or Without Ultrasound Correlates, Multiple Architectural Distortions Still Warrant Biopsy. AJR. American Journal Of Roentgenology 2022, 13. PMID: 36000669, DOI: 10.2214/AJR.22.28374.
- Equalizing the Performance of Radiologists and Physician Extenders in Screening Mammography.Hooley R, Durand M. Equalizing the Performance of Radiologists and Physician Extenders in Screening Mammography. Radiology 2022, 306: 110-111. PMID: 36098645, DOI: 10.1148/radiol.221960.
- Editorial Comment: Appropriate Management of Architectural Distortion Detected on Digital Breast Tomosynthesis.Durand MA. Editorial Comment: Appropriate Management of Architectural Distortion Detected on Digital Breast Tomosynthesis. AJR. American Journal Of Roentgenology 2021, 217: 854. PMID: 33236651, DOI: 10.2214/AJR.20.25090.
- Digital Breast Tomosynthesis for Women Older Than 70 YearsDurand MA, Philpotts L. Digital Breast Tomosynthesis for Women Older Than 70 Years. JAMA Internal Medicine 2019, 179: 853-853. PMID: 31157846, DOI: 10.1001/jamainternmed.2019.1234.
- Good News for Older Women Undergoing Screening Mammography with Digital Breast Tomosynthesis.Philpotts LE, Durand MA. Good News for Older Women Undergoing Screening Mammography with Digital Breast Tomosynthesis. Radiology 2019, 291: 591-593. PMID: 30942669, DOI: 10.1148/radiol.2019190426.
- Retroareolar masses and intraductal abnormalities detected on screening ultrasound: can biopsy be avoided?Guo Y, Raghu M, Durand M, Hooley R. Retroareolar masses and intraductal abnormalities detected on screening ultrasound: can biopsy be avoided? British Journal Of Radiology 2018, 91: 20170816. PMID: 29338316, PMCID: PMC6350469, DOI: 10.1259/bjr.20170816.
- Chapter 5 Tomosynthesis in Screening MammographyDurand M, Philpotts L. Chapter 5 Tomosynthesis in Screening Mammography. 2018, 26-38. DOI: 10.1016/b978-0-323-35827-9.00005-8.
- Advances in Digital Breast Tomosynthesis.Hooley RJ, Durand MA, Philpotts LE. Advances in Digital Breast Tomosynthesis. American Journal Of Roentgenology 2016, 208: 256-266. PMID: 27786548, DOI: 10.2214/ajr.16.17127.
- Can Tomosynthesis Replace 2D Mammography as a Future Breast Screening Tool?Durand M, Philpotts L. Can Tomosynthesis Replace 2D Mammography as a Future Breast Screening Tool? Current Breast Cancer Reports 2016, 8: 213-220. DOI: 10.1007/s12609-016-0224-5.
- In Vivo Changes of Breast Perfusion After Augmentation.Teng E, Broer PN, Heidekrueger PI, Forte AJ, Lentz R, Durand M, Raghu M, Kwei SL. In Vivo Changes of Breast Perfusion After Augmentation. Aesthetic Surgery Journal 2016, 36: 1133-1140. PMID: 27625032, DOI: 10.1093/asj/sjw139.
- Tomosynthesis in the Diagnostic Setting: Changing Rates of BI-RADS Final Assessment over Time.Raghu M, Durand MA, Andrejeva L, Goehler A, Michalski MH, Geisel JL, Hooley RJ, Horvath LJ, Butler R, Forman HP, Philpotts LE. Tomosynthesis in the Diagnostic Setting: Changing Rates of BI-RADS Final Assessment over Time. Radiology 2016, 281: 54-61. PMID: 27139264, DOI: 10.1148/radiol.2016151999.
- Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense and Nondense BreastsRafferty EA, Durand MA, Conant EF, Copit DS, Friedewald SM, Plecha DM, Miller DP. Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense and Nondense Breasts. JAMA 2016, 315: 1784-1786. PMID: 27115381, DOI: 10.1001/jama.2016.1708.
Clinical Trials
Conditions | Study Title |
---|---|
Breast - Female | I-SPY 2 Trial (Investigation of Serial Studies to Predict Your Therapeutic Response With Imaging And moLecular Analysis 2) |